KN-62 analogues as potent differentiating agents of HL-60 cells
- 11 September 2006
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 31 (5) , 683-689
- https://doi.org/10.1016/j.leukres.2006.07.022
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Synthesis and Biological Activity of N-Arylpiperazine-Modified Analogues of KN-62, a Potent Antagonist of the Purinergic P2X7 ReceptorJournal of Medicinal Chemistry, 2003
- IL-3–induced enhancement of retinoic acid receptor activity is mediated through Stat5, which physically associates with retinoic acid receptors in an IL-3–dependent mannerBlood, 2002
- The role of retinoids and retinoic acid receptors in normal hematopoiesisLeukemia, 2002
- Acute promyelocytic leukemia: evolving therapeutic strategiesBlood, 2002
- Ca2+/CaM-Dependent Kinases: From Activation to FunctionAnnual Review of Pharmacology and Toxicology, 2001
- Role of the histone deacetylase complex in acute promyelocytic leukaemiaNature, 1998
- Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APLNature Genetics, 1998
- NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3).1991
- 5-Isoquinolinesulfonamide derivatives. 1. Synthesis and vasodilatory activity of N-(2-guanidinoethyl)-5-isoquinolinesulfonamide derivativesJournal of Medicinal Chemistry, 1989
- Activation of the multifunctional Ca2+/calmodulin-dependent protein kinase by autophosphorylation: ATP modulates production of an autonomous enzyme.Proceedings of the National Academy of Sciences, 1986